Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Iterum Therapeutics plc CEO and leadership

Zippia score 3.6
OverviewRevenue

Reviews

CEO & Executives

Iterum Therapeutics plc CEO and executives

Executive Summary. Based on our data team's research, Corey N. Fishman is the Iterum Therapeutics plc's CEO. Iterum Therapeutics plc has 48 employees, of which 14 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Iterum Therapeutics plc executive team is 36% female and 64% male.
  • 63% of the management team is White.
  • 9% of Iterum Therapeutics plc management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Iterum Therapeutics plc?
Share your experience

Rate Iterum Therapeutics plc's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Corey N. Fishman

CEO

Corey N. Fishman's LinkedIn

Corey N. Fishman has served as our Chief Operating Officer since August 2010 and as our Chief Financial Officer since June 2012. From 2008 to 2010, Mr. Fishman served as Chief Financial Officer of GANIC Pharmaceuticals, Inc. From 2006 to 2008, he served as Chief Financial Officer of MedPointe Inc. until its acquisition by Meda AB. Mr. Fishman holds a B.A. in Economics from the University of Illinois at Urbana-Champaign and an M.S.M. in Finance from the Krannert School of Management at Purdue University.

John White

Founder

Judith M. Matthews

Chief Financial Officer

Judith M. Matthews's LinkedIn

Judith M Matthews is a Chief Financial Officer at Iterum Therapeutics and is based in Chicago, Illinois. She has worked as Senior at Pricewaterhouse Coopers (PwC), VP:Finance at Durata Therapeutics, and Financial Reporting Manager at RR DONNELLEY & SONS CO. Judith studied at KELLOGG SCHOOL OF MANAGEMENT between 1999 and 2002 and University of Illinois between 1987 and 1991.

Louise Barrett

Senior Vice President

Steven I. Aronin

Senior Vice President & Head-Clinical Development

Tom Loughman

Senior Vice President

Sailaja Puttagunta

Chief Medical Officer

Mark Chin

Board Member

Ronald M. Hunt

Board Member

Beth P. Hecht

Board Member

Do you work at Iterum Therapeutics plc?

Does the leadership team provide a clear direction for Iterum Therapeutics plc?

Iterum Therapeutics plc jobs

Iterum Therapeutics plc founders

Name & TitleBio
Corey N. Fishman

CEO

Corey N. Fishman's LinkedIn

Corey N. Fishman has served as our Chief Operating Officer since August 2010 and as our Chief Financial Officer since June 2012. From 2008 to 2010, Mr. Fishman served as Chief Financial Officer of GANIC Pharmaceuticals, Inc. From 2006 to 2008, he served as Chief Financial Officer of MedPointe Inc. until its acquisition by Meda AB. Mr. Fishman holds a B.A. in Economics from the University of Illinois at Urbana-Champaign and an M.S.M. in Finance from the Krannert School of Management at Purdue University.

John White

Founder

Iterum Therapeutics plc board members

Name & TitleBio
Corey N. Fishman

CEO

Corey N. Fishman's LinkedIn

Corey N. Fishman has served as our Chief Operating Officer since August 2010 and as our Chief Financial Officer since June 2012. From 2008 to 2010, Mr. Fishman served as Chief Financial Officer of GANIC Pharmaceuticals, Inc. From 2006 to 2008, he served as Chief Financial Officer of MedPointe Inc. until its acquisition by Meda AB. Mr. Fishman holds a B.A. in Economics from the University of Illinois at Urbana-Champaign and an M.S.M. in Finance from the Krannert School of Management at Purdue University.

Sailaja Puttagunta

Chief Medical Officer

Mark Chin

Board Member

Ronald M. Hunt

Board Member

Beth P. Hecht

Board Member

Brenton K. Ahrens

Chairman

Michael W. Dunne M.d

Board Member

David George Kelly

Board Member

Arix Bioscience

Board Member

Iterum Therapeutics plc executives FAQs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Iterum Therapeutics plc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Iterum Therapeutics plc. The employee data is based on information from people who have self-reported their past or current employments at Iterum Therapeutics plc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Iterum Therapeutics plc. The data presented on this page does not represent the view of Iterum Therapeutics plc and its employees or that of Zippia.

Iterum Therapeutics plc may also be known as or be related to ITERUM THERAPEUTICS PLC, Iterum Therapeutics, Iterum Therapeutics Ltd, Iterum Therapeutics Ltd. and Iterum Therapeutics plc.